Diagnosis and Lab Tests for IMD99
At a Glance
IMD99 diagnosis requires a combination of tests, not one result: doctors review antibody levels and blood counts, assess vaccine responses and immune-cell patterns, and use genetic testing while checking for other causes of low antibodies. This helps explain infection risk and autoimmune cytopenias.
Diagnosing Immunodeficiency 99 (IMD99) is a bit like solving a complex puzzle. While many people are familiar with Common Variable Immunodeficiency (CVID)—a clinical diagnosis made using defined immunoglobulin and functional-response findings after excluding secondary causes—IMD99 is a more specific, “gene-defined” diagnosis [1][2]. Some patients with monogenic disease have a CVID-like phenotype.
Getting a precise diagnosis through genetic testing and detailed blood work is vital. It moves you from a clinical category into a specific one, which helps your doctors understand exactly why your immune system is both underactive and overactive [1][3]. Your doctor will also perform a secondary-cause review to ensure your hypogammaglobulinemia isn’t caused by medication exposure, protein loss, hematologic malignancy, renal or gastrointestinal disease, or recent transfusion.
Essential Laboratory Tests
Your doctors use three “layers” of testing to monitor your health and refine your diagnosis.
Layer 1: The Foundation (CBC and Basic Immunoglobulins)
- Complete Blood Count (CBC) with Differential: This is the most common test. It counts your red blood cells, white blood cells, and platelets [4]. In IMD99, doctors use this to track autoimmune cytopenias (low blood counts caused by immune attack) [5].
- Quantitative Immunoglobulins (IgG, IgA, IgM): These measure the total amount of different antibody types in your blood [6]. Low levels of these, especially IgG, explain why you may get frequent infections [7].
- Coombs Test (Direct Antiglobulin Test or DAT): This specific test looks for antibodies that are stuck to the surface of your red blood cells [8]. A positive DAT does not by itself prove active autoimmune hemolytic anemia; it can occur without hemolysis (including after transfusion or IgRT). Conversely, a negative test does not completely exclude hemolysis. Doctors pair DAT interpretation with hemoglobin trend, reticulocyte count, bilirubin, LDH, haptoglobin, and blood-film findings [9].
Layer 2: Functional Testing (Vaccine Responses)
Having antibodies is one thing; having antibodies that work is another. Doctors perform vaccine challenge tests to see if your body can produce new, protective antibodies after a shot (like the pneumonia or tetanus vaccine) [10][11]. Note that pneumococcal and tetanus titers require age-, assay-, vaccine-, and timing-specific interpretation and can be confounded by IVIG therapy; they do not by themselves “confirm” a functional deficiency [11].
Layer 3: Advanced Mapping (Immunophenotyping)
This advanced test, often done via flow cytometry, acts like a “map” of your immune cells [12]. It looks at specific subsets of cells:
- Switched Memory B Cells: If these are low, it may be associated with B-cell “factories” struggling to mature and remember past germs [13].
- CD21-low B Cells: High levels of these specific cells are sometimes associated with immune dysregulation and are frequently seen in patients who have autoimmune issues alongside their immunodeficiency [13][14].
- Regulatory T Cells (Tregs): These are the “peacekeeper” cells. Routine measurement of Treg number does not establish Treg function, but they are an important part of the research into immune dysregulation [15].
Genetic Testing
While blood tests show what is happening, genetic testing attempts to show why. By sequencing your DNA, doctors look for the specific mutation that causes IMD99 [1]. However, genetic sequencing is not universally the “final answer”: it can be negative, identify a variant of uncertain significance (VUS), or require segregation and functional evidence [16][17]. Genetic counseling is highly recommended to interpret inheritance and family testing.
Your Lab Completeness Checklist
When you review your medical portal or talk to your doctor, ensure these key values have been discussed:
| Category | Key Values to Look For |
|---|---|
| Antibody Levels | IgG, IgA, IgM (Total levels) |
| Blood Counts | Hemoglobin, Platelets, Absolute Neutrophil Count (ANC) |
| Cell Subsets | B Cells (Naïve vs. Switched Memory), T Cells (CD4+, CD8+), NK Cells |
| Autoimmune Markers | Direct Coombs Test (DAT), Reticulocyte count, LDH, Haptoglobin |
| Function | Pneumococcal titers (Pre- and Post-vaccination) |
| Genetics | Genetic sequencing report and genetic counseling |
Note: Always interpret these results with your immunology specialist, as “normal” ranges can vary based on your age and whether you are currently receiving immunoglobulin therapy [10][18]. Not every item in the checklist is required for every patient.
Common questions in this guide
What tests help diagnose IMD99?
What does low IgG mean in IMD99?
Can a Coombs test show whether IMD99 is attacking my red blood cells?
How do vaccine antibody tests measure immune function in IMD99?
What do switched-memory and CD21-low B-cell results mean?
Can genetic testing be inconclusive for IMD99?
What is the absolute neutrophil count, and why is it important?
Get notified when new evidence is published on immunodeficiency 99 with hypogammaglobulinemia and autoimmune cytopenias.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (18)
- 1
There is no gene for CVID - novel monogenetic causes for primary antibody deficiency.
Ramirez NJ, Posadas-Cantera S, Caballero-Oteyza A, et al.
Current opinion in immunology 2021; (72()):176-185 doi:10.1016/j.coi.2021.05.010.
PMID: 34153571 - 2
Perspective: Application of the American College of Medical Genetics Variant Interpretation Criteria to Common Variable Immunodeficiency Disorders.
Ameratunga R, Allan C, Lehnert K, Woon ST
Clinical reviews in allergy & immunology 2021; (61(2)):226-235 doi:10.1007/s12016-020-08828-z.
PMID: 33818703 - 3
"Common variable immunodeficiency: Challenges for diagnosis".
Wang LA, Abbott JK
Journal of immunological methods 2022; (509()):113342 doi:10.1016/j.jim.2022.113342.
PMID: 36027932 - 4
Peripheral-blood cytopenia, an early indicator of inborn errors of immunity.
Cornelissen HM, Musekwa EM, Glashoff RH, et al.
British journal of haematology 2022; (198(5)):875-886 doi:10.1111/bjh.18337.
PMID: 35791731 - 5
Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.
Zama D, Conti F, Moratti M, et al.
Immunity, inflammation and disease 2021; (9(2)):583-594 doi:10.1002/iid3.420.
PMID: 33838017 - 6
Investigating Biomarkers for Inborn Errors of Immunity in a Prospective Study of Patients With Autoimmune Cytopenia.
Gaál Z, Meehan C, Yilmaz M, et al.
Pediatric blood & cancer 2026; (73(3)):e70074 doi:10.1002/1545-5017.70074.
PMID: 41560547 - 7
Immunoglobulin replacement therapy in primary and secondary antibody deficiency: The correct clinical approach.
Pecoraro A, Crescenzi L, Granata F, et al.
International immunopharmacology 2017; (52()):136-142 doi:10.1016/j.intimp.2017.09.005.
PMID: 28898770 - 8
Autoimmune Cytopenias in Common Variable Immunodeficiency Are a Diagnostic and Therapeutic Conundrum: An Update.
Chawla S, Barman P, Tyagi R, et al.
Frontiers in immunology 2022; (13()):869466 doi:10.3389/fimmu.2022.869466.
PMID: 35795667 - 9
Dual Autoimmunity: Evans Syndrome and Multiple Sclerosis.
Markl A, Warren M, Iskander J, et al.
Cureus 2026; (18(8)):e113997 doi:10.7759/cureus.113997.
PMID: 42698986 - 10
How to use immunoglobulin levels in investigating immune deficiencies.
Ladomenou F, Gaspar B
Archives of disease in childhood. Education and practice edition 2016; (101(3)):129-35 doi:10.1136/archdischild-2015-309060.
PMID: 26987724 - 11
Tonsillar granuloma associated with hypogammaglobulinemia.
Laajala A, Kuismin O, Tastula M, et al.
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2020; (16()):43 doi:10.1186/s13223-020-00441-1.
PMID: 32514274 - 12
EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.
van Dongen JJM, van der Burg M, Kalina T, et al.
Frontiers in immunology 2019; (10()):1271 doi:10.3389/fimmu.2019.01271.
PMID: 31263462 - 13
Predominantly Antibody-Deficient Patients With Non-infectious Complications Have Reduced Naive B, Treg, Th17, and Tfh17 Cells.
Edwards ESJ, Bosco JJ, Aui PM, et al.
Frontiers in immunology 2019; (10()):2593 doi:10.3389/fimmu.2019.02593.
PMID: 31803177 - 14
The TH1 phenotype of follicular helper T cells indicates an IFN-γ-associated immune dysregulation in patients with CD21low common variable immunodeficiency.
Unger S, Seidl M, van Schouwenburg P, et al.
The Journal of allergy and clinical immunology 2018; (141(2)):730-740 doi:10.1016/j.jaci.2017.04.041.
PMID: 28554560 - 15
Chronically Activated T-cells Retain Their Inflammatory Properties in Common Variable Immunodeficiency.
Berbers RM, van der Wal MM, van Montfrans JM, et al.
Journal of clinical immunology 2021; (41(7)):1621-1632 doi:10.1007/s10875-021-01084-6.
PMID: 34247288 - 16
Next-generation sequencing for inborn errors of immunity.
Lee K, Abraham RS
Human immunology 2021; (82(11)):871-882 doi:10.1016/j.humimm.2021.02.011.
PMID: 33715910 - 17
Evaluating the Genetics of Common Variable Immunodeficiency: Monogenetic Model and Beyond.
de Valles-Ibáñez G, Esteve-Solé A, Piquer M, et al.
Frontiers in immunology 2018; (9()):636 doi:10.3389/fimmu.2018.00636.
PMID: 29867916 - 18
Hypogammaglobulinemia, late-onset neutropenia, and infections following rituximab.
Athni TS, Barmettler S
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2023; (130(6)):699-712 doi:10.1016/j.anai.2023.01.018.
PMID: 36706910
This page is for informational purposes only and does not constitute medical advice about IMD99. An immunologist, hematologist, or genetic counselor should interpret your results and plan follow-up, especially if you receive immunoglobulin therapy.